Steve Vintz
Analyst · Morgan Stanley. Please proceed with your question
Thanks, Amit. We are pleased with our results for the third quarter highlighted by good top line growth, a sizable beat in EPS, and strong unlevered free cash flow. I will provide more commentary momentarily, but first please note that all financial results we discuss today are non-GAAP financial measures with the exception of revenue. As Erin mentioned at the start of this call, GAAP to non-GAAP reconciliations may be found in our earnings release issued earlier today, which is posted on our website. Now, on to the results for the quarter. Calculated current billings defines the change in current deferred revenue plus revenue recognized in the quarter grew 24% year-over-year to 207.3 million and benefited from our continued investment and our platform strategy and go to market efforts. As Amit mentioned earlier, we had one of our best quarters in terms of adding new customers and transacting large deals. Specifically, we added 712 new enterprise platform customers and 89 net new six figure customers in Q3, which represents 43% and 44% growth year-over-year respectively. Underpinning customer momentum is our exposure solutions, which is helping us become more strategic to our customers and translating to larger deal sizes. New deals aside, our platform is also creating a more compelling upsell path for existing customers and is benefiting our dollar based net expansion rate or DBNER, which was 118% in the quarter. We plan to disclose our DBNER [Technical Difficulty] going forward in our quarterly filings to provide further visibility into the broader adoption of our platform and other products. While DBNER may fluctuate on a quarterly basis, we generally expect it to be within 110% to 120% range. Revenue was 174.9 million, which represents 26% year-over-year growth and was up from 23% growth in Q3 last year. Revenue in the quarter exceeded the mid-point of our guided range by 4.9 million. Visibility remains high as our percentage of recurring revenue was 95%, which is consistent with prior periods. Now, I'll turn to expense where we are achieving operating leverage while continuing to invest for growth. I'll start with gross margin, which was 81% flat compared to last quarter. Cost of goods sold increased sequentially in absolute dollars, primarily due to the increased usage of our cloud based products and the initial costs related to the release of Tenable One, which includes attack path analysis and external attack surface management. Sales and marketing expense was 74.5 million, which was down from 75.6 million last quarter. Sales and marketing expense as a percent of revenue was 43%, compared to 46% last quarter, reflecting greater efficiency in our go to market efforts. Q3 expense reflects increased quota carrying sales reps, and go to market personnel, as well as higher commission. R&D expense was 27.4 million, which was down from 28.1 million last quarter. R&D expense decreased sequentially due to lower contractor spend in connection with the recent release of Tenable One, offset by incremental engineering headcount and less capitalized software development costs. R&D expense as a percentage of revenue was 16%, which was slightly lower than last quarter. G&A expense was 16.7 million, which was down from 17.3 million last quarter. G&A decreased sequentially due to more efficient global operations, partially offset by increased company events and travel. As a percentage of revenue, G&A expense was 10% this quarter, compared to 11% last quarter. Income from operations was 23.1 million, a notable 13.6 million above the mid-point of our guided range, due to the outperformance in revenue and lower operating expenses, including lower payroll costs. The takeaway here is, as a company, we have a lot of natural leverage in our business and remain focused on increasing the efficiency, with which we build, market, and sell our products while we continue to invest in key growth areas such as sales and R&D. EPS in the quarter was $0.15, which was over $0.11 better than the mid-point of our guided range. In terms of FX, a stronger dollar resulted in an FX loss of $0.02 per share in other expense in the quarter offset by approximately $0.01 benefit above the line in OpEx, due to lower operating costs in local currency. Now, let's turn to the balance sheet. We finished the quarter with 548 million in cash and short-term investments. Accounts receivable was 147.9 million and total deferred revenue was 593.7 million, including [447.9] [ph] of current deferred revenue, which gives us a lot of visibility into revenue over the next twelve months. Now, I would like to discuss interest expense and income. Looking ahead, we are assuming a higher interest rate environment when our floating rate debt facility reset at the end of October. Consequently, our full-year guidance reflects 1.1 million of additional interest expense than our previously provided guidance. However, earnings on our cash and investment balances provide a natural hedge to interest expense in a rising rate environment. As such, we do not expect that interest expense, net of interest income will have a significant impact on EPS. We generated 34.8 million of unlevered free cash flow, which is a 20% margin. With 95% recurring revenue, high-gross margin, and renewal rates, we feel confident that we can continue to generate attractive levels of cash flow, while continuing to invest in the business. With the results of the quarter behind us, I'd like to discuss our outlook for the fourth quarter and full-year 2022. For the fourth quarter, we currently expect revenue to be in the range of 180 million to 182 million, non-GAAP income from operations to be in the range of 15 million to 16 million. Non-GAAP net income to be in the range of 7.5 million to 8.5 million, assuming interest expense of 6.8 million and a provision for income taxes of 2.8 million. Non-GAAP diluted earnings per share to be in the range of $0.06, $0.07 assuming a 118.5 million fully-diluted weighted average shares outstanding. And for the full-year, we currently expect calculated current billings to be in the range of 768 million to 776 million, revenue to be in the range of 678.6 million to 680.6 million, non-GAAP income from operations to be in the range of 62.7 million to 63.7 million, non-GAAP net income to be in the range of 37.6 million to 38.6 million, assuming interest expense of 19 million and a provision for income taxes of 6 million. Non-GAAP diluted earnings per share to be in the range of $0.32 to $0.33. Our EPS guidance assumes 118 million only diluted weighted average shares outstanding, and unlevered free cash flow to be in the range of 122 million to 125 million. Today, we are reiterating our full-year guidance for calculated current billings of 768 million to 776 million, representing 25% growth at the midpoint. As we discussed earlier, we are pleased with our execution in the third quarter, but given the backdrop of an uncertain macro, we believe this is a prudent approach. For revenue, which has more visibility, we are raising our full-year guidance by 3.6 million at the mid-point in recognition of the upside we achieved in Q3. In terms of operating income at the midpoint, we are passing along the [13.6 million] [ph] in Q3 and raising the full-year by approximately 2 million as we continue to scale efficiently across the globe. We are also providing a full-year unlevered free cash flow guide for the first time today, which reflects the confidence we have in our business to significantly grow cash flow over time. At this point, I like to turn the call back over to Amit.